Dose Regimen Rationale for Panitumumab in Cancer Patients: To Be Based on Body Weight or Not

od Liao, Michael Z, Berkhout, Marloes, Prenen, Hans, Dutta, Sandeep, Upreti, Vijay V
Izdano u Clin Pharmacol (2020)

Is Bodyweight-Based Dosing Truly Better Than Flat Dosing for Panitumumab? [Response to Letter]

od Liao, Michael Z, Kast, Johannes, Berkhout, Marloes, Prenen, Hans, Dutta, Sandeep, Upreti, Vijay V
Izdano u Clin Pharmacol (2020)

Mechanisms of MDMA (Ecstasy)-Induced Oxidative Stress, Mitochondrial Dysfunction, and Organ Damage

od Song, Byoung-Joon, Moon, Kwan-Hoon, Upreti, Vijay V., Eddington, Natalie D., Lee, Insong J.
Izdano 2010

Drug Interaction Between Ethanol and 3,4-Methylenedioxymethamphetamine (“ecstasy”)

od Upreti, Vijay V., Eddington, Natalie D., Moon, Kwan-Hoon, Song, Byoung-Joon, Lee, Insong J.
Izdano 2009

Effect of rifampicin on the pharmacokinetics and pharmacodynamics of saxagliptin, a dipeptidyl peptidase-4 inhibitor, in healthy subjects

od Upreti, Vijay V, Boulton, David W, Li, Li, Ching, Agatha, Su, Hong, LaCreta, Frank P, Patel, Chirag G
Izdano 2011

Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor

od Upreti, Vijay V, Song, Yan, Wang, Jessie, Byon, Wonkyung, Boyd, Rebecca A, Pursley, Janice M, LaCreta, Frank, Frost, Charles E
Izdano 2013

Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects

od Upreti, Vijay V, Wang, Jessie, Barrett, Yu Chen, Byon, Wonkyung, Boyd, Rebecca A, Pursley, Janice, LaCreta, Frank P, Frost, Charles E
Izdano 2013

Mechanism of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-mediated mitochondrial dysfunction in rat liver

od Moon, Kwan-Hoon, Upreti, Vijay V., Yu, Li-Rong, Lee, Insong J., Ye, Xiaoying, Eddington, Natalie D., Veenstra, Timothy D., Song, Byoung-Joon
Izdano 2008

Increased oxidative-modifications of cytosolic proteins in 3, 4-methylenedioxymethamphetamine (MDMA, Ecstasy)-exposed rat liver

od Upreti, Vijay V., Moon, Kwan-Hoon, Yu, Li-Rong, Lee, Insong J., Eddington, Natalie D., Ye, Xiaoying, Veenstra, Timothy D., Song, Byoung-Joon
Izdano 2010

Evaluation of the Transport, In Vitro Metabolism and Pharmacokinetics of Salvinorin A, a Potent Hallucinogen

od Teksin, Zeynep S., Lee, Insong J., Nemieboka, Noble N., Othman, Ahmed A., Upreti, Vijay V., Hassan, Hazem E., Syed, Shariq S., Prisinzano, Thomas E., Eddington, Natalie D.
Izdano 2009

Dose escalation results from a first-in-human, phase 1 study of glucocorticoid-induced TNF receptor–related protein agonist AMG 228 in patients with advanced solid tumors

od Tran, Ben, Carvajal, Richard D., Marabelle, Aurelien, Patel, Sandip Pravin, LoRusso, Patricia M., Rasmussen, Erik, Juan, Gloria, Upreti, Vijay V., Beers, Courtney, Ngarmchamnanrith, Gataree, Schöffski, Patrick
Izdano u J Immunother Cancer (2018)

VN/14-1 induces ER stress and autophagy in HP-LTLC human breast cancer cells and has excellent oral pharmacokinetic profile in female Sprague Dawley rats

od Godbole, Abhijit M., Ramalingam, Senthilmurugan, Ramamurthy, Vidya P., Khandelwal, Aakanksha, Bruno, Robert D., Upreti, Vijay V., Gediya, Lalji K., Purushottamachar, Puranik, Mbatia, Hannah W., Addya, Sankar, Ambulos, Nicholas, Njar, Vincent C. O.
Izdano 2014

Recommendations for the Design of Clinical Drug–Drug Interaction Studies With Itraconazole Using a Mechanistic Physiologically‐Based Pharmacokinetic Model

od Chen, Yuan, Cabalu, Tamara D., Callegari, Ernesto, Einolf, Heidi, Liu, Lichuan, Parrott, Neil, Peters, Sheila Annie, Schuck, Edgar, Sharma, Pradeep, Tracey, Helen, Upreti, Vijay V., Zheng, Ming, Zhu, Andy Z.X., Hall, Stephen D.
Izdano u CPT Pharmacometrics Syst Pharmacol (2019)